We are live on
!
Find out more
EPFB
Employees Provident Fund Board Portfolio holdings
AUM
$17.4B
1-Year Est. Return
49.08%
This Fund
S&P 500
This Quarter
Est. Return
+23.32%
1 Year Est. Return
+49.08%
3 Year Est. Return
+125.51%
5 Year Est. Return
+167.05%
10 Year Est. Return
+526.03%
AUM
$4.4B
AUM Growth
+$724M
(+20%)
Cap. Flow
-$26.6M
Cap. Flow
% of AUM
-0.6%
Top 10 Holdings %
Top 10 Hldgs %
41.72%
Holding
70
New
9
Increased
21
Reduced
21
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$47.6M |
| 2 |
Pfizer
PFE
|
+$44.5M |
| 3 |
Biogen
BIIB
|
+$39.5M |
| 4 |
Johnson & Johnson
JNJ
|
+$36.9M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$34.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$142M |
| 2 |
Oracle
ORCL
|
+$49.8M |
| 3 |
Meta Platforms (Facebook)
META
|
+$40.2M |
| 4 |
Dollar General
DG
|
+$32.3M |
| 5 |
Apple
AAPL
|
+$31.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.33% |
| 2 | Financials | 17.21% |
| 3 | Healthcare | 10.19% |
| 4 | Communication Services | 8.74% |
| 5 | Materials | 6.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Freeport-McMoran
FCX
$96.7B
| $18.6M | 0.42% |
1,607,697
| – | – |
|
52
Scotiabank
BNS
$107B
| $18.2M | 0.41% |
324,347
| – | – |
|
53
Franco-Nevada
FNV
$48.4B
| $12.9M | 0.29% |
+67,873
| New | +$9.02M |
|
54
Manulife Financial
MFC
$72B
| $12.4M | 0.28% |
670,757
| – | – |
|
55
Moody's
MCO
$86.1B
| $10.5M | 0.24% |
+38,070
| New | +$9.67M |
|
|
ANSS
56
DELISTED
Ansys
ANSS
| $5.43M | 0.12% |
+18,609
| New | +$4.96M |
|
57
Ross Stores
ROST
$75.3B
| $4.43M | 0.1% |
+51,964
| New | +$4.71M |
|
58
Southern Copper
SCCO
$164B
| $4.13M | 0.09% |
113,338
+98,880
| +684% | +$3.09M |
|
59
AbbVie
ABBV
$470B
| $3.81M | 0.09% |
+38,789
| New | +$3.42M |
|
60
Adobe
ADBE
$108B
| $1.38M | 0.03% |
+3,180
| New | +$1.18M |
|
61
Palo Alto Networks
PANW
$293B
| $308K | 0.01% |
8,034
-136,800
| -94% | -$4.82M |
|
|
62
Merck
MRK
$376B
| $255K | 0.01% |
3,458
-1,885,639
| -100% | -$142M |
|
63
Synopsys
SNPS
$76.8B
| $156K | ﹤0.01% |
800
| – | – |
|
64
Agnico Eagle Mines
AEM
$105B
| – | – |
-236,424
| Closed | -$13.3M |
|
65
Amgen
AMGN
$239B
| – | – |
-39,898
| Closed | -$8.09M |
|
66
Dow Inc
DOW
$22.9B
| – | – |
-460,596
| Closed | -$13.5M |
|
67
EOG Resources
EOG
$78.4B
| – | – |
-90,224
| Closed | -$3.24M |
|
|
68
Oracle
ORCL
$414B
| – | – |
-1,030,678
| Closed | -$49.8M |
|
69
Qualcomm
QCOM
$170B
| – | – |
-315,869
| Closed | -$21.4M |
|
Similar funds
LCOV
EIP
DCM
WA
AI
HWM
AIMCA
TI
Employees Provident Fund Board's Q2 2020 Portfolio in Review
As of Q2 2020, Employees Provident Fund Board held 70 positions worth $4.4B, up 20% from $3.68B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Employees Provident Fund Board's Q2 2020 filing shows 9 new, 21 increased, 21 reduced and 6 closed positions. Its largest new stake was Procter & Gamble: 408,037 shares worth $48.8M. The largest sale was Merck, an estimated $142M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Financials and Healthcare.
- Employees Provident Fund Board's largest Q2 2020 buy was Procter & Gamble: 408,037 shares worth $48.8M.
- Employees Provident Fund Board added most to Pfizer in Q2 2020, an estimated $44.5M increase.
- Employees Provident Fund Board's biggest Q2 2020 reduction was Merck, cutting an estimated $142M.
- Employees Provident Fund Board fully exited Oracle in Q2 2020, selling an estimated $49.8M.
- Employees Provident Fund Board's ten largest holdings make up 42% of its $4.4B portfolio in Q2 2020.
- Employees Provident Fund Board opened 9 new positions and closed 6 in Q2 2020.
- Employees Provident Fund Board's portfolio value rose 20% quarter-over-quarter to $4.4B.
Based on Employees Provident Fund Board's 13F filing for Q2 2020, filed 18 Mar 2026.